Neumora Therapeutics (NMRA) stock

Worth $87.7MShares as of Aug 10

$0.47

-3.97%

As of Tuesday's close · Live for Pro members at the open

Not scored

Breakaway doesn't score NMRA. It is priced too low for a fair Quality Score.

Healthcare · Biotech

NextQ4 2026 or 2H 2026“…and NMRA-898 in schizophrenia with clinical data expected in fourth quarter of 2026 and second half of…”Trial data · SEC filing · Aug 14

Cash$117M, about 2 quarters at the last year's spendingOn Jun 30 · the company says “into the third quarter of 2027”

Follow NMRA's news. Pro members can get an alert when Neumora Therapeutics files news, and see its trials, share raises, and its CEO's filings.

Get an alert when NMRA files newsSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. 3,168 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.

Cash$117M, about 2 quarters at the last year's spendingOn Jun 30 · the company says “into the third quarter of 2027”

What's next for NMRA, and how long its cash lasts

Next step the company has named

Q4 2026“Progressing NMRA-511 in Alzheimer’s disease (AD) agitation and NMRA-898 in schizophrenia with clinical data expected in fourth quarter of 2026 and second half of 2026, respectively”Trial data · SEC filing · Aug 14

What it means: the first look at a trial’s main results, as the company reports them.

Lead program: NMRA-511

For Pro members: 4 more milestones and 32 filings.

Cash runway Jun 30 balance sheet

About 2 quarters

$117M in cash and short-term investments, at its spending over the last year

What it means: how long the cash would last at the same pace, before any new money. The company's estimate is “into the third quarter of 2027” (8-K, Aug 14).

For Pro members: the cash used each quarter, and the math.

Dilution on the horizon

Shelf registration (S-3ASR, filed Oct 1, 2024)
At-the-market share sales program (S-3ASR, filed Oct 1, 2024)

For Pro members: the amounts, and the share count against a year ago.

Insiders

An officer, Daljit Singh Aurora, sold 176,060 shares on Aug 21. 5 more insider trades this year.

From Form 4: open-market buys and sales only.

Get an alert when Joshua Pinto buys or sells

For Pro members: every trade, and Joshua Pinto’s 8 filings and quotes.

Get an alert when NMRA files newsA free account. No card.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

In 12 daysFDA decisionIn 12 days · FDA decisionCAPRCapricor TherapeuticsDeramiocelCAPRCapricor Therapeutics · $500MDeramiocelFDA decision due (PDUFA)
In 12 daysFDA decisionIn 12 days · FDA decisionSVRASavaraMolgramostimSVRASavara · $900MMolgramostimFDA decision due (PDUFA)
In 42 daysFDA decisionIn 42 days · FDA decisionMLYSMineralys TherapeuticsLorundrostatMLYSMineralys Therapeutics · $1.3BLorundrostatFDA decision due (PDUFA)

14 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 151 dates, ranked →

NMRA's latest filings

A notice about its exchange listing8-K, filed Oct 30
5 insider filingsForm 4, filed Aug 21
Quarterly report10-Q, filed Aug 14

17 more filings in the last year, for Pro members

From SEC EDGAR, as filed. Each opens the filing on the SEC's site.

Why NMRA isn't scored

The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. NMRA trades at $0.47. A stock that clears every mark is scored from the next weekly rebuild.

Straight AnswersStraight Answers

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.